148 related articles for article (PubMed ID: 30250546)
1. Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfection.
Zhou C; Zhang L; Xu P
Oncol Lett; 2018 Oct; 16(4):4813-4820. PubMed ID: 30250546
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Survivin by shRNA Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma.
Hu J; Pan J; Luo Z; Tao Z
Cell Biochem Biophys; 2015 May; 72(1):251-7. PubMed ID: 25701406
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
6. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
[TBL] [Abstract][Full Text] [Related]
7. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
8. Survivin shRNA induces caspase-3-dependent apoptosis and enhances cisplatin sensitivity in squamous cell carcinoma of the tongue.
Xu JH; Wang AX; Huang HZ; Wang JG; Pan CB; Zhang B
Oncol Res; 2010; 18(8):377-85. PubMed ID: 20441052
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis.
Qin Q; Chen H; Xu H; Zhang X; Chen J; Zhang C; Liu J; Xu L; Sun X
J Cancer; 2023; 14(3):454-463. PubMed ID: 36860922
[TBL] [Abstract][Full Text] [Related]
10. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
Huang Q; Zeng Y; Lin H; Zhang H; Yang D
Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer.
Li C; Zhu M; Lu Q; Yu B; Yang Y; Li B; Peng Z; Li Z
Ann Transl Med; 2023 Mar; 11(5):193. PubMed ID: 37007541
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
15. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
[TBL] [Abstract][Full Text] [Related]
16. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
[TBL] [Abstract][Full Text] [Related]
18. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.
Khan Z; Khan AA; Yadav H; Prasad GBKS; Bisen PS
Cell Mol Biol Lett; 2017; 22():8. PubMed ID: 28536639
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
Wang S; Huang X; Lee CK; Liu B
Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]